Asset Allocation
| Position | Category/Sector | Target Weight |
|---|---|---|
ALNY Alnylam Pharmaceuticals, Inc. | Healthcare | 10% |
AMGN Amgen Inc. | Healthcare | 13% |
AZN AstraZeneca PLC | Healthcare | 11% |
HIMS Hims & Hers Health, Inc. | Consumer Defensive | 1% |
LLY Eli Lilly and Company | Healthcare | 15% |
MCK McKesson Corporation | Healthcare | 8% |
NVO Novo Nordisk A/S | Healthcare | 15% |
REGN Regeneron Pharmaceuticals, Inc. | Healthcare | 10% |
TEVA Teva Pharmaceutical Industries Limited | Healthcare | 10% |
VKTX Viking Therapeutics, Inc. | Healthcare | 7% |
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in GLP Weigh Loss , comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.
Loading graphics...
The earliest data available for this chart is Sep 13, 2019, corresponding to the inception date of HIMS
Returns By Period
| 1D | 1M | YTD | 6M | 1Y | 3Y* | 5Y* | 10Y* | |
|---|---|---|---|---|---|---|---|---|
Benchmark S&P 500 Index | 0.11% | -3.43% | -3.84% | -1.98% | 16.08% | 16.86% | 10.37% | 12.29% |
Portfolio GLP Weigh Loss | -0.21% | -2.69% | -5.46% | 8.30% | 20.99% | 25.85% | 29.22% | — |
| Portfolio components: | ||||||||
NVO Novo Nordisk A/S | 1.37% | 4.40% | -24.78% | -34.84% | -43.28% | -20.60% | 3.97% | 5.03% |
MCK McKesson Corporation | 1.37% | -11.19% | 7.89% | 16.76% | 28.01% | 35.09% | 36.27% | 19.69% |
LLY Eli Lilly and Company | -1.98% | -7.16% | -12.80% | 14.47% | 15.19% | 39.72% | 39.64% | 31.19% |
AMGN Amgen Inc. | -1.51% | -7.71% | 7.04% | 18.64% | 17.39% | 16.07% | 10.31% | 11.72% |
REGN Regeneron Pharmaceuticals, Inc. | -1.98% | -0.63% | -1.18% | 27.29% | 22.44% | -2.45% | 10.06% | 6.59% |
AZN AstraZeneca PLC | 1.37% | 0.86% | 12.99% | 24.18% | 44.83% | 15.99% | 18.18% | 16.94% |
ALNY Alnylam Pharmaceuticals, Inc. | -3.01% | 0.06% | -19.82% | -30.83% | 19.50% | 16.68% | 17.59% | 16.79% |
TEVA Teva Pharmaceutical Industries Limited | -0.56% | -6.82% | -3.62% | 50.02% | 96.73% | 48.85% | 21.25% | -5.34% |
VKTX Viking Therapeutics, Inc. | 5.58% | 8.99% | -1.08% | 24.82% | 35.51% | 25.58% | 40.84% | 37.04% |
HIMS Hims & Hers Health, Inc. | -3.53% | 20.99% | -41.05% | -66.93% | -38.69% | 22.90% | 7.07% | — |
Monthly Returns
Based on dividend-adjusted daily data since Sep 16, 2019, GLP Weigh Loss 's average daily return is +0.11%, while the average monthly return is +2.27%. At this rate, your investment would double in approximately 2.6 years.
Historically, 63% of months were positive and 38% were negative. The best month was Feb 2024 with a return of +20.2%, while the worst month was Oct 2020 at -8.5%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 4 months.
On a daily basis, GLP Weigh Loss closed higher 53% of trading days. The best single day was Feb 27, 2024 with a return of +14.1%, while the worst single day was Mar 12, 2020 at -9.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.41% | -0.24% | -6.22% | 0.63% | -5.46% | ||||||||
| 2025 | 1.19% | 4.57% | -6.74% | 0.71% | -0.64% | 0.58% | -1.15% | 5.14% | 1.57% | 7.03% | 12.86% | -0.71% | 25.76% |
| 2024 | 8.35% | 20.24% | 4.85% | -0.64% | 6.26% | 8.53% | 0.09% | 7.58% | -6.87% | -3.80% | -4.93% | -5.31% | 35.94% |
| 2023 | 0.05% | -2.43% | 9.45% | 5.34% | -2.57% | 0.64% | 0.67% | 9.16% | -1.39% | -4.02% | 8.22% | 7.72% | 33.81% |
| 2022 | -6.24% | 2.73% | 9.11% | -4.44% | 2.33% | -0.12% | 4.10% | 1.65% | -3.40% | 13.39% | 5.48% | 11.91% | 40.43% |
| 2021 | 10.80% | -4.11% | 0.76% | 0.47% | 2.64% | 7.45% | 2.93% | 5.27% | -4.79% | 1.61% | -2.19% | 4.25% | 26.80% |
Benchmark Metrics
GLP Weigh Loss has an annualized alpha of 20.30%, beta of 0.70, and R² of 0.38 versus S&P 500 Index. Calculated based on daily prices since September 16, 2019.
- This portfolio captured 100.25% of S&P 500 Index gains but only 28.83% of its losses — a favorable profile for investors.
- Beta of 0.70 may look defensive, but with R² of 0.38 this portfolio is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
- R² of 0.38 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 20.30%
- Beta
- 0.70
- R²
- 0.38
- Upside Capture
- 100.25%
- Downside Capture
- 28.83%
Expense Ratio
GLP Weigh Loss has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Return for Risk
Risk / Return Rank
GLP Weigh Loss ranks 25 for risk / return — below 25% of portfolios on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
| Portfolio | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.86 | 0.88 | -0.03 |
Sortino ratioReturn per unit of downside risk | 1.31 | 1.37 | -0.06 |
Omega ratioGain probability vs. loss probability | 1.16 | 1.21 | -0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.74 | 1.39 | +0.35 |
Martin ratioReturn relative to average drawdown | 5.21 | 6.43 | -1.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.
| Risk / Return Rank | Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio | |
|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 11 | -0.80 | -0.97 | 0.87 | -0.78 | -1.35 |
MCK McKesson Corporation | 73 | 0.97 | 1.65 | 1.22 | 2.33 | 6.05 |
LLY Eli Lilly and Company | 51 | 0.36 | 0.78 | 1.11 | 0.56 | 1.37 |
AMGN Amgen Inc. | 59 | 0.60 | 1.07 | 1.13 | 1.10 | 2.65 |
REGN Regeneron Pharmaceuticals, Inc. | 59 | 0.56 | 0.97 | 1.14 | 1.07 | 2.72 |
AZN AstraZeneca PLC | 84 | 1.66 | 2.36 | 1.31 | 3.46 | 8.67 |
ALNY Alnylam Pharmaceuticals, Inc. | 54 | 0.48 | 0.97 | 1.12 | 0.66 | 1.45 |
TEVA Teva Pharmaceutical Industries Limited | 91 | 2.30 | 3.09 | 1.42 | 4.44 | 12.79 |
VKTX Viking Therapeutics, Inc. | 59 | 0.46 | 1.11 | 1.17 | 1.01 | 2.23 |
HIMS Hims & Hers Health, Inc. | 25 | -0.38 | 0.03 | 1.00 | -0.49 | -0.96 |
Loading graphics...
Dividends
Dividend yield
GLP Weigh Loss provided a 1.56% dividend yield over the last twelve months.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio | 1.56% | 1.22% | 1.09% | 0.93% | 1.00% | 1.11% | 1.29% | 1.33% | 1.37% | 1.83% | 2.14% | 1.41% |
| Portfolio components: | ||||||||||||
NVO Novo Nordisk A/S | 4.87% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
MCK McKesson Corporation | 0.36% | 0.37% | 0.47% | 0.50% | 0.54% | 0.72% | 0.95% | 1.16% | 1.32% | 0.80% | 0.80% | 0.53% |
LLY Eli Lilly and Company | 0.67% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
AMGN Amgen Inc. | 2.78% | 2.91% | 3.45% | 2.96% | 2.95% | 3.13% | 2.78% | 2.41% | 2.71% | 2.65% | 2.74% | 1.95% |
REGN Regeneron Pharmaceuticals, Inc. | 0.47% | 0.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AZN AstraZeneca PLC | 2.62% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
ALNY Alnylam Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
VKTX Viking Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HIMS Hims & Hers Health, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the GLP Weigh Loss . A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the GLP Weigh Loss was 29.72%, occurring on Apr 8, 2025. Recovery took 160 trading sessions.
The current GLP Weigh Loss drawdown is 9.07%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -29.72% | Sep 3, 2024 | 150 | Apr 8, 2025 | 160 | Nov 25, 2025 | 310 |
| -21.83% | Feb 13, 2020 | 27 | Mar 23, 2020 | 18 | Apr 17, 2020 | 45 |
| -16.67% | Jul 21, 2020 | 73 | Oct 30, 2020 | 52 | Jan 15, 2021 | 125 |
| -14.94% | Apr 11, 2022 | 47 | Jun 16, 2022 | 33 | Aug 4, 2022 | 80 |
| -13.76% | Aug 16, 2022 | 29 | Sep 26, 2022 | 24 | Oct 28, 2022 | 53 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Diversification
Diversification Metrics
Number of Effective Assets
The portfolio contains 10 assets, with an effective number of assets of 8.67, reflecting the diversification based on asset allocation. This number of effective assets indicates a moderate level of diversification, where some assets may have a more significant influence on overall performance.
Asset Correlations Table
| Benchmark | HIMS | MCK | TEVA | ALNY | VKTX | AZN | NVO | LLY | REGN | AMGN | Portfolio | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Benchmark | 1.00 | 0.37 | 0.32 | 0.41 | 0.34 | 0.36 | 0.29 | 0.36 | 0.35 | 0.36 | 0.40 | 0.54 |
| HIMS | 0.37 | 1.00 | 0.07 | 0.21 | 0.24 | 0.27 | 0.10 | 0.17 | 0.13 | 0.12 | 0.13 | 0.30 |
| MCK | 0.32 | 0.07 | 1.00 | 0.23 | 0.12 | 0.13 | 0.24 | 0.19 | 0.28 | 0.27 | 0.35 | 0.41 |
| TEVA | 0.41 | 0.21 | 0.23 | 1.00 | 0.27 | 0.29 | 0.24 | 0.21 | 0.21 | 0.23 | 0.26 | 0.53 |
| ALNY | 0.34 | 0.24 | 0.12 | 0.27 | 1.00 | 0.34 | 0.22 | 0.22 | 0.25 | 0.34 | 0.28 | 0.55 |
| VKTX | 0.36 | 0.27 | 0.13 | 0.29 | 0.34 | 1.00 | 0.23 | 0.26 | 0.25 | 0.26 | 0.25 | 0.61 |
| AZN | 0.29 | 0.10 | 0.24 | 0.24 | 0.22 | 0.23 | 1.00 | 0.43 | 0.38 | 0.34 | 0.39 | 0.55 |
| NVO | 0.36 | 0.17 | 0.19 | 0.21 | 0.22 | 0.26 | 0.43 | 1.00 | 0.45 | 0.34 | 0.30 | 0.60 |
| LLY | 0.35 | 0.13 | 0.28 | 0.21 | 0.25 | 0.25 | 0.38 | 0.45 | 1.00 | 0.37 | 0.40 | 0.64 |
| REGN | 0.36 | 0.12 | 0.27 | 0.23 | 0.34 | 0.26 | 0.34 | 0.34 | 0.37 | 1.00 | 0.49 | 0.60 |
| AMGN | 0.40 | 0.13 | 0.35 | 0.26 | 0.28 | 0.25 | 0.39 | 0.30 | 0.40 | 0.49 | 1.00 | 0.61 |
| Portfolio | 0.54 | 0.30 | 0.41 | 0.53 | 0.55 | 0.61 | 0.55 | 0.60 | 0.64 | 0.60 | 0.61 | 1.00 |